On the upside
SandRidge Energy (NYSE: SD) shareholder TPG-Axon Capital Management asked the board of directors to fire chief executive Tom Ward and sell the company.
benzinga.com reported that Whiting Petroleum (NYSE: WLL) received an acquisition offer from Statoil. On the downside
Catalyst Pharmaceutical Partners (Nasdaq: CPRX) reported disappointing results from a Phase II(b) clinical trial of its cocaine addiction treatment CPP-109.
BioCryst (Nasdaq: BCRX) terminated a Phase 3 trial of its serious influenza treatment peramivir.
Universal Panel (Nasdaq: PANL) fell to an unexpected loss for the third quarter as revenue plunged.
In the broad market, advancing issues barely edged out decliners by a slim margin on both the NYSE and on Nasdaq. The Russell 2000 which tracks small cap stocks held steady at 804.